CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Indapta Therapeutics, INC.

For profitWebsite ↗

Also known as: Indapta Therapeutics, INC. | Indaptus Therapeutics, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 1, 2024

Timeline

2010s

Jun 1, 2017
Indapta Therapeutics, INC.— Founded

Drugs by trial phase (9 distinct, 3 trials)

Phase 2 (8 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

ocrelizumab

Recent trials (6)

NCT06677710Lead sponsorPhase 1Nov 1, 2024
NCT06677710OfficialPhase 1Nov 1, 2024
NCT06119685Lead sponsorPhase 1/Phase 2Oct 25, 2023
NCT06119685Study directorPhase 1/Phase 2Oct 25, 2023
NCT05651022Lead sponsorPhase 1/Phase 2Feb 28, 2023
NCT05651022OfficialPhase 1/Phase 2Feb 28, 2023

Details

Founded: San Francisco, CA, US Jun 1, 2017
Last known activity: Nov 1, 2024